Literature DB >> 17587637

Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii.

Hongfa Wang1, Quan Liu, Keyi Liu, Weixia Zhong, Shengyan Gao, Li Jiang, Na An.   

Abstract

Toxoplasma gondii is an obligate intracellular parasite, capable of infecting a variety of mammals and birds. Development of vaccine against T. gondii would be of great medical and veterinary value. In this study, the DNA sequence encoding ROP2 from T. gondii was cloned into the muticopy mycobacterial expression vector, pMV262, under the control of the Bacillus Calmette-Guerin (BCG) hsp60 promoter, and electroporated into BCG. Following selection of kanamycin, the recombinant BCG/pMV262-ROP2 was constructed and the expression of ROP2 was confirmed by Western blotting. The BALB/c mice inoculated with the BCG/pMV262-ROP2 developed specific immune responses against ROP2 protein, and there was an obvious delay in the mortality curve than the control (P<0.05). These results indicated that M. bovis BCG is an adequate vector to express and present antigens of T. gondii, and it may be used to further study the induction of protective immunity in other animals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587637     DOI: 10.1016/j.parint.2007.04.003

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  19 in total

1.  Construction and identification of Complex DNA vaccine of hepatitis B and Toxoplasma gondii.

Authors:  Qing-Kuan Wei; Ting Xiao; Jin Li; Kun Yin; Feng-Ju Jia; Chao Xu; Gui-Hua Zhao; Yong Cui; Gong-Zhen Liu; Hui Sun; Hong-Tao Jiang; Ge Yan; Bing-Cheng Huang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis.

Authors:  M M Liu; Z G Yuan; G H Peng; D H Zhou; X H He; C Yan; C C Yin; Y He; R Q Lin; H Q Song; X Q Zhu
Journal:  Parasitol Res       Date:  2010-02-23       Impact factor: 2.289

3.  Recombinant ROP2, ROP4, GRA4 and SAG1 antigen-cocktails as possible tools for immunoprophylaxis of toxoplasmosis: what's next?

Authors:  Bozena Dziadek; Anna Brzostek
Journal:  Bioengineered       Date:  2012-08-15       Impact factor: 3.269

4.  Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice.

Authors:  Pei-Yuan Wang; Zi-Guo Yuan; Eskild Petersen; Jie Li; Xiu-Xiang Zhang; Xiu-Zhen Li; Hao-Xin Li; Zhi-Cheng Lv; Tian Cheng; Di Ren; Gui-Lian Yang; Rui-Qing Lin; Xing-Quan Zhu
Journal:  Clin Vaccine Immunol       Date:  2012-09-26

5.  Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice.

Authors:  Zi-Guo Yuan; Xiu-Xiang Zhang; Xian-Hui He; Eskild Petersen; Dong-Hui Zhou; Yong He; Rui-Qing Lin; Xiu-Zhen Li; Xu-Li Chen; Xiao-Ru Shi; Xiu-Ling Zhong; Bing Zhang; Xing-Quan Zhu
Journal:  Clin Vaccine Immunol       Date:  2010-11-24

6.  Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses.

Authors:  Wen-Shu Li; Qing-Xin Chen; Ju-Xiu Ye; Zi-Xin Xie; Jun Chen; Li-Fang Zhang
Journal:  Parasitol Res       Date:  2011-03-15       Impact factor: 2.289

7.  Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.

Authors:  Susan M Bueno; Pablo A González; Kelly M Cautivo; Jorge E Mora; Eduardo D Leiva; Hugo E Tobar; Glenn J Fennelly; Eliseo A Eugenin; William R Jacobs; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

8.  Optimisation of bioluminescent reporters for use with mycobacteria.

Authors:  Nuria Andreu; Andrea Zelmer; Taryn Fletcher; Paul T Elkington; Theresa H Ward; Jorge Ripoll; Tanya Parish; Gregory J Bancroft; Ulrich Schaible; Brian D Robertson; Siouxsie Wiles
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

Review 9.  Protein kinases of Toxoplasma gondii: functions and drug targets.

Authors:  Feng Wei; Wei Wang; Quan Liu
Journal:  Parasitol Res       Date:  2013-05-17       Impact factor: 2.289

10.  Eimeria maxima: efficacy of recombinant Mycobacterium bovis BCG expressing apical membrane antigen1 against homologous infection.

Authors:  Wen-Chao Li; Xu-ke Zhang; Ling Du; Le Pan; Peng-Tao Gong; Jian-Hua Li; Ju Yang; He Li; Xi-Chen Zhang
Journal:  Parasitol Res       Date:  2013-08-15       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.